Increased commitment to Ferrosan Medical Devices
Strategic Investments /06.09.2018
Kirk Kapital has further increased its investment, by subscribing to a preference share class
In 2016, Kirk Kapital acquired a 30% ownership interest in Ferrosan Medical Devices (“FMD”), which we today own together with majority shareholder, Impilo, and select private individuals. In connection with a larger refinancing of FMD completed in August 2018, Kirk Kapital has further increased its investment, by subscribing to a preference share class.
“FMD is a high quality company, well-known to KIRK, and we value the partnership with Impilo. In this light, we are pleased to increase our investment in the company”, says the CEO of Kirk Kapital, Kim Gulstad.
Ferrosan Medical Devices (FMD) is a leading developer and manufacturer of absorbable hemostatic products used to stop bleeding during surgery, as well as miniature electrical engineering used in equipment for regional anesthesia and minimal invasive surgery. The hemostatic products are distributed world-wide through a partnership with Ethicon (a Johnson&Johnson company), one of the world’s leaders in the market for equipment for human surgery.
Morten Huse Eikrem-Jeppesen, PressConnect for Kirk Kapital, +45 53 85 07 70